|
Waldenstrom's macroglobulinemia is a rare, chronic cancer of the immune system that is characterized by hyperviscosity, or thickening, of the blood.
|
|
Waldenstrom's macroglobulinemia is a rare, chronic cancer of the immune system that is characterized by hyperviscosity, or thickening, of the blood.
|
|
Antineoplastic agent; nitrogen mustard derivative; alkylating agent.
|
|
Chlorambucil (marketed under the brand name Leukeran) is a chemotherapy medicine used to treat cancer by interfering with the growth of cancer cells. Purpose Chlorambucil is approved by the Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and malignant lymphomas.
|
|
Antineoplastic agent; nitrogen mustard derivative; alkylating agent.
|
|
Antineoplastic agent and immunosuppressant; nitrogen mustard-derivative alkylating agent.
|
|
Cyclophosphamide is an anticancer (antineoplastic) agent. It also acts as a suppressor of the immune system.
|
|
Cyclophosphamide is a cancer (chemotherapeutic) medication. Cyclophosphamide interferes
with the growth of cancer cells and slows their growth and spread in the body.
|
|
Fludarabine is a cancer medication that interferes with the growth and spread of cancer
cells in the body.
|
|
Fludarabine is a chemotherapy medicine used to treat certain types of cancer by destroying cancerous cells. It is known as the brand name Fludara.
|
|
Antimetabolite antineoplastic agent; synthetic purine antagonist.
|
|
Chlorambucil is a cancer medication that interferes with cancer cells and slows their
growth and spread in the body.
|
|
Melphalan is a cancer medication. Melphalan interferes with the growth of cancer cells
and slows their growth and spread in the body.
|
|
Melphalan is an anticancer (antineoplastic) agent. It also acts as a suppressor of the immune system.
|
|
Rituximab is a cancer medication that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Rituximab is a humanized monoclonal antibody that selectively binds to CD20, a protein found on the surface of normal and malignant B cells and is used to reduce the numbers of circulating B cells in patients who have B-cell non-Hodgkin ' s lymphoma (NHL). Rituximab is sold as Rituxan in the United States.
|
|
Antineoplastic agent; a chimeric human-murine anti-human antigen CD20 monoclonal antibody.
|